Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | IL1RN | P18510 | 2/20 | 0.47 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.47 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | REN | P00797 | 1/20 | 0.43 |
| ▸ | ACACB | O00763 | 2/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL313030 | 0.95 | MEN1 (0.54) | ALDH1A1MEN1LMNAKMT2AITGB3 | |
| SCHEMBL313085 | 0.89 | ITGB3 (0.50) | ALDH1A1MEN1LMNAKMT2AITGB3 | |
| SCHEMBL313677 | 0.86 | ITGB3 (0.48) | ALDH1A1MEN1LMNAKMT2AITGB3 | |
| SCHEMBL313537 | 0.82 | MEN1 (0.58) | ALDH1A1MEN1LMNAKMT2AGAA | |
| SCHEMBL1862350 | 0.82 | MEN1 (0.61) | ALDH1A1MEN1LMNAKMT2AGAA | |
| SCHEMBL1856782 | 0.82 | TSHR (0.62) | ALDH1A1KMT2AIL1RNERAP2ERAP1 | |
| SCHEMBL1860016 | 0.81 | GAA (0.51) | ALDH1A1MEN1LMNAKMT2AGAA | |
| SCHEMBL1858694 | 0.81 | ALDH1A1 (0.56) | ALDH1A1MEN1LMNAKMT2AITGB3 | |
| SCHEMBL3734223 | 0.80 | ALDH1A1 (0.68) | ALDH1A1LMNATSHRTHRBCYP2C9 | |
| SCHEMBL5706152 | 0.80 | ACACB (0.58) | ALDH1A1KMT2AITGB3ITGA2BGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8436201-B2 | Functionalized diphenolics and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2013-05-07 | — | — | US | disclosed |
| US-8436201-B2 | Functionalized diphenolics and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2013-05-07 | — | — | US | disclosed |
| US-8436201-B2 | Functionalized diphenolics and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2013-05-07 | — | — | US | disclosed |
| US-20130041045-A1 | FUNCTIONALIZED DIPHENOLICS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2013-02-14 | — | — | US | disclosed |
| US-20130041045-A1 | FUNCTIONALIZED DIPHENOLICS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2013-02-14 | — | — | US | disclosed |
| US-20130041045-A1 | FUNCTIONALIZED DIPHENOLICS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2013-02-14 | — | — | US | disclosed |
| US-8288505-B2 | Functionalized diphenolics and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2012-10-16 | — | — | US | disclosed |
| US-8288505-B2 | Functionalized diphenolics and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2012-10-16 | — | — | US | disclosed |
| US-8288505-B2 | Functionalized diphenolics and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2012-10-16 | — | — | US | disclosed |
| US-20110223254-A1 | FUNCTIONALIZED DIPHENOLICS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2011-09-15 | — | — | US | disclosed |
| US-20110223254-A1 | FUNCTIONALIZED DIPHENOLICS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2011-09-15 | — | — | US | disclosed |
| US-20110223254-A1 | FUNCTIONALIZED DIPHENOLICS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2011-09-15 | — | — | US | disclosed |
| US-7935843-B2 | Functionalized diphenolics and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2011-05-03 | — | — | US | disclosed |
| US-7935843-B2 | Functionalized diphenolics and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2011-05-03 | — | — | US | disclosed |
| US-7935843-B2 | Functionalized diphenolics and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2011-05-03 | — | — | US | disclosed |
| US-20070135355-A1 | FUNCTIONALIZED DIPHENOLICS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2007-06-14 | — | — | US | disclosed |
| US-20070135355-A1 | FUNCTIONALIZED DIPHENOLICS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2007-06-14 | — | — | US | disclosed |
| US-20070135355-A1 | FUNCTIONALIZED DIPHENOLICS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130041045-A1 | FUNCTIONALIZED DIPHENOLICS AND ABSORBABLE POLYMERS THEREFROM | DDT, DHCR7, NOTUM | ALDH1A1 905/4885MEN1 3155/4885LMNA 3505/4885 |
| US-20070135355-A1 | FUNCTIONALIZED DIPHENOLICS AND ABSORBABLE POLYMERS THEREFROM | DDT, DHCR7, NOTUM | ALDH1A1 905/4885MEN1 3155/4885LMNA 3505/4885 |
| US-20110223254-A1 | FUNCTIONALIZED DIPHENOLICS AND ABSORBABLE POLYMERS THEREFROM | DDT, DHCR7, NOTUM | ALDH1A1 905/4885MEN1 3155/4885LMNA 3505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.